{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:34:27Z","timestamp":1772764467609,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.encep.2007.10.006","type":"journal-article","created":{"date-parts":[[2008,1,16]],"date-time":"2008-01-16T11:31:41Z","timestamp":1200483101000},"page":"409-415","source":"Crossref","is-referenced-by-count":25,"title":["Les anti\u00e9pileptiques thymor\u00e9gulateurs dans le traitement des sympt\u00f4mes comportementaux et psychologiques de la d\u00e9mence (SCPD)"],"prefix":"10.1016","volume":"34","author":[{"given":"D.","family":"Pinheiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2007.10.006_bib1","first-page":"505","article-title":"Carbamazepine in senile dementia and overactivity \u2013 a placebo-controlled double blind trial","volume":"10","author":"Chambers","year":"1982","journal-title":"IRCS J Med Sci"},{"key":"10.1016\/j.encep.2007.10.006_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4088\/JCP.v61n0114f","article-title":"Combination of donepezil and gabapentin for behavioral disorders in Alzheimer's disease","volume":"61","author":"Dallocchio","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2007.10.006_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.jcp.0000117431.83724.b0","article-title":"Treatment of psychotic symptoms with lamotrigine in Alzheimer disease","volume":"24","author":"De Le\u00f3n","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.encep.2007.10.006_bib4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/appi.ajp.157.7.1178","article-title":"Aggression in dementia with lamotrigine treatment","volume":"157","author":"Devarajan","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2007.10.006_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00004714-198608000-00007","article-title":"Carbamazepine in dementia","volume":"6","author":"Essa","year":"1986","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2007.10.006_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/bmj.318.7176.106","article-title":"Fortnightly review: drug treatment of epilepsy","volume":"318","author":"Feely","year":"1999","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.encep.2007.10.006_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S1041610203009554","article-title":"Treatment of aggressive behaviour in dementia with the anticonvulsant topiramate: a retrospective pilot study","volume":"15","author":"Fhager","year":"2003","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.encep.2007.10.006_bib8","first-page":"115","article-title":"Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics","volume":"51","author":"Gleason","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.10.006_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/10401239709147789","article-title":"Divalproex: a possible alternative for demented, elderly aggressive patients","volume":"9","author":"Haas","year":"1997","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2007.10.006_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/appi.ajgp.8.3.221","article-title":"A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias","volume":"8","author":"Hawkins","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2007.10.006_bib11","first-page":"229","article-title":"Hyponatremia due to sodium valproate","volume":"19","author":"Herment","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/070674379804300108","article-title":"Valproic acid treatment of agitation in dementia","volume":"43","author":"Herrmann","year":"1998","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00004714-200002000-00015","article-title":"Effectiveness of gabapentin for the treatment of behavioral disorders in dementia","volume":"20","author":"Herrmann","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2007.10.006_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000097757","article-title":"A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease","volume":"23","author":"Herrmann","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4088\/JCP.v63n0114a","article-title":"Valproate-induced parkinsonism in a demented elderly patient","volume":"63","author":"Iijima","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1099-1166(199801)13:1<29::AID-GPS726>3.0.CO;2-Z","article-title":"The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances","volume":"13","author":"Kunik","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"10.1016\/j.encep.2007.10.006_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/070674370404900705","article-title":"GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target fot the treatment of behavioural and psychological symptoms of dementia","volume":"49","author":"Lanct\u00f4t","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2007.10.006_bib18","first-page":"767","article-title":"Prise en charge des troubles du comportement dans les d\u00e9mences","volume":"156","author":"Lebert","year":"2000","journal-title":"Rev Neurol"},{"key":"10.1016\/j.encep.2007.10.006_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.38125.465579.55","article-title":"Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review","volume":"329","author":"Lee","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.encep.2007.10.006_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/089198878800100208","article-title":"Carbamazepine treatment of agitation associated with dementia","volume":"1","author":"Leibovici","year":"1988","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"8","key":"10.1016\/j.encep.2007.10.006_bib21","first-page":"354","article-title":"Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics","volume":"56","author":"Lemke","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.10.006_bib22","doi-asserted-by":"crossref","unstructured":"Lonergan ET, Luxenberg J. Valproate preparations for agitation in dementia. Cochrane review. In: The Cochrane Library, Oxford: 2004: issue 4.","DOI":"10.1002\/14651858.CD003945.pub2"},{"issue":"3","key":"10.1016\/j.encep.2007.10.006_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/jnp.7.3.314","article-title":"Valproate in the treatment of behavioral agitation in elderly patients with dementia","volume":"7","author":"Lott","year":"1995","journal-title":"J Neuropsychiatr Clin Neurosci"},{"issue":"5","key":"10.1016\/j.encep.2007.10.006_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00004714-199910000-00020","article-title":"Gabapentin for the management of agitation","volume":"19","author":"Low","year":"1999","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2007.10.006_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1385\/JMN:19:3:301","article-title":"Neuroprotective properties of valproate: potential benefit for AD and tauopathies","volume":"19","author":"Loy","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.encep.2007.10.006_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.52.2.321","article-title":"Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults","volume":"52","author":"Martin","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.encep.2007.10.006_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/089198879300600404","article-title":"Sodium valproate in the treatment of behavioral disturbance in dementia","volume":"6","author":"Mellow","year":"1993","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"4","key":"10.1016\/j.encep.2007.10.006_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1345\/aph.10217","article-title":"Gabapentin for treatment of behavioral and psychological symptoms of dementia","volume":"35","author":"Miller","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"14","key":"10.1016\/j.encep.2007.10.006_bib29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00002512-200320140-00003","article-title":"Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation","volume":"20","author":"Moretti","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.encep.2007.10.006_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4088\/JCP.v58n0804","article-title":"Treatment of dementia with behavioral disturbance using valproex or a combination of divalproex and a neuroleptic","volume":"58","author":"Narayan","year":"1997","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2007.10.006_bib31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00019442-200111000-00008","article-title":"A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease","volume":"9","author":"Olin","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/089198878800100105","article-title":"A preliminary study of carbamazepine in the treatment of assaultive patients with dementia","volume":"1","author":"Patterson","year":"1988","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"4","key":"10.1016\/j.encep.2007.10.006_bib33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00019442-199700540-00010","article-title":"An open trial of valproate for agitation in geriatric neuropsychiatric disorders","volume":"5","author":"Porsteinsson","year":"1997","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1176\/appi.ajgp.9.1.58","article-title":"Placebo-controlled study of divalproex sodium for agitation in dementia","volume":"9","author":"Porsteinsson","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2007.10.006_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1176\/appi.ajgp.11.4.434","article-title":"Valproate therapy for agitation in dementia: extension of a double-blind trial","volume":"11","author":"Porsteinsson","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2007.10.006_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2174\/156720505774932205","article-title":"A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease","volume":"2","author":"Profenno","year":"2005","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"10.1016\/j.encep.2007.10.006_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.jcp.0000132447.65972.3d","article-title":"Gabapentin and behavioral disorders in severe Alzheimer disease","volume":"24","author":"Raudino","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004714-199702000-00015","article-title":"Gabapentin for behavioral agitation in Alzheimer's disease","volume":"17","author":"Regan","year":"1997","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1176\/jnp.12.1.40","article-title":"Treatment of dementia-associated agitation with gabapentin","volume":"12","author":"Roane","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.encep.2007.10.006_bib40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1532-5415.1994.tb06571.x","article-title":"The effects of sodium valproate on disturbed behaviour in dementia","volume":"42","author":"Sival","year":"1994","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.encep.2007.10.006_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/gps.653","article-title":"Sodium valproate in the treatment of aggressive behaviour in patients with dementia \u2013 a randomized placebo-controlled clinical trial","volume":"17","author":"Sival","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.encep.2007.10.006_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(98)00580-9","article-title":"Lamotrigin inhibits monoamin uptake in vitro and modulates 5-hydroxytryptamine uptake in rats","volume":"358","author":"Southam","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.encep.2007.10.006_bib43","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1532-5415.1994.tb06982.x","article-title":"Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study","volume":"42","author":"Tariot","year":"1994","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.encep.2007.10.006_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1176\/ajp.155.1.54","article-title":"Efficacy and tolerability of carbamazepine for agitation and aggression in dementia","volume":"155","author":"Tariot","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.10.006_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0011-393X(01)80042-4","article-title":"Safety and tolerability of divalproex sodium for the treatment of symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial","volume":"62","author":"Tariot","year":"2001","journal-title":"Curr Ther Res"},{"issue":"12","key":"10.1016\/j.encep.2007.10.006_bib46","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0169-409X(02)00153-9","article-title":"Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales","volume":"54","author":"Tariot","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.encep.2007.10.006_bib47","first-page":"942","article-title":"Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial","volume":"13","author":"Tariot","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.encep.2007.10.006_bib48","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.69.5.636","article-title":"Effects of topiramate on cognitive function","volume":"69","author":"Thompson","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700607001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700607001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T20:26:33Z","timestamp":1557174393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700607001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0013700607001121"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2007.10.006","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}